| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 4.446 | 27.764 | 4.781 | 15.928 | 5.644 |
| Total Income - EUR | - | - | - | - | - | 4.446 | 27.786 | 4.781 | 15.928 | 5.644 |
| Total Expenses - EUR | - | - | - | - | - | 6.298 | 39.394 | 5.041 | 11.023 | 28.205 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -1.852 | -11.609 | -260 | 4.905 | -22.561 |
| Net Profit/Loss - EUR | - | - | - | - | - | -1.985 | -11.871 | -398 | 4.905 | -22.561 |
| Employees | - | - | - | - | - | 0 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Takebio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 9.852 | 20.786 | 18.569 | 27.470 | 1.728 |
| Inventories | - | - | - | - | - | 3.938 | 10.011 | 15.071 | 18.724 | 0 |
| Receivables | - | - | - | - | - | 5.578 | 10.689 | 2.847 | 6.464 | 0 |
| Cash | - | - | - | - | - | 336 | 85 | 652 | 2.282 | 1.728 |
| Shareholders Funds | - | - | - | - | - | 82 | -11.791 | -12.225 | -7.283 | -29.803 |
| Social Capital | - | - | - | - | - | 2.067 | 2.022 | 2.028 | 2.022 | 2.010 |
| Debts | - | - | - | - | - | 9.770 | 32.576 | 30.795 | 34.752 | 31.531 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Takebio S.r.l.